On Thursday we profiled Kāhu SiliconBio, the University of Edinburgh spinout building a bioelectronic sensor platform. The Edinburgh Reporter is now reporting that the company has secured a £1.2 million funding package from the German Federal Agency for Disruptive Innovation (SPRIN-D) to advance its real-time hormone monitoring technology and adapt it for women’s health applications.
According to the Edinburgh Reporter, the award forms part of the SPRIND Continuous Hormone Monitoring Challenge, a €40m European initiative aiming to develop biosensors capable of measuring multiple hormones over seven days. The prototype is designed to continuously track hormone levels throughout the day and could support research into conditions such as endometriosis and polycystic ovary syndrome (PCOS). Co-founded by Professor Teuta Pilizota and Dr James Flewellen, Kāhu SiliconBio has previously received support from IBioIC, Scottish Enterprise, Innovate UK, Silicon Catalyst UK and the Roslin Institute Campus Innovation Account.
Dr James Flewellen, co-founder and chief executive of Kāhu SiliconBio, said: “Hormones play a fundamental role in health, but we still have limited visibility into how they change throughout our lives and how those fluctuations relate to disease. This funding will help us take an important step towards creating a new type of biological sensor that could give both researchers and patients a much deeper understanding of hormone patterns and their impact on women’s health.”
Read our earlier profile: Meet Kāhu SiliconBio — the University of Edinburgh spinout building bioelectronic sensors.
